Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (ps) derivatives and their copper(i) complexes against mtor and hdac enzymes as highly potent and effective new anticancer therapeutic drugs

HIGHLIGHTS

• who: . et al. from the Sungkyunkwan University, South Korea China have published the Article: Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (Ps) derivatives and their Copper(I) complexes against mTOR and HDAC enzymes as highly potent and effective new anticancer therapeutic drugs, in the Journal: (JOURNAL)
• what: In this study, a series of 1,10-phenanthroline and Prodigiosin (Ps) derivatives consisting of their 2:1 ligand-to-metal copper(I) complexes, as PF6- salts, have been isolated and characterized.

SUMMARY

The targeted inhibition of HDAC . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.